Jorge Gomez, M.D., Ph.D.
Dr. Jorge Gomez is a Senior Advisor in NCI's Center fro Global Health (CGH) focused on supporting and advancing international collaboration and partnerships in scientific and clinical cancer research, training, and infrastructure development in Latin America.
Dr. Gomez was born in Empalme Sonora, Mexico and received his medical degree at the Universidad de Guadalajara School of Medicine. In 1982, Dr. Gomez came to the United States where he completed a Master of Science in immunology at the University of Texas at El Paso and then went on to obtain a doctorate degree in immunology and pharmacology from the University of Arizona. After completing his doctoral studies, Dr. Gomez continued his training as a postdoctoral fellow at Thomas Jefferson University.
Dr. Gomez joined NIH in 1992 as a postdoctoral trainee at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) and in 1994, he was selected for the Grants Associate Program, a one-year training program for research scientists in science administration. After completion of the program, Dr. Gomez joined the Organ Systems Branch (OSB) at NCI where he served as Program Director of the Breast Cancer Program under the Specialized Programs of Research Excellence (SPORE), a translational program bridging laboratory research with the treatment of patients in the clinical care setting.
In 1998, Dr. Gomez became chief of OSB where he oversaw the management and administration of the SPORE program for ten years. In this capacity, Dr. Gomez was responsible for a $130 million portfolio of grants that comprised over 600 research projects, 200 research cores, and 255 clinical research studies including 150 clinical trials. Dr. Gomez was honored with the 2006 Medical Advancement in Breast Cancer Award from the Avon Foundation for his work on the Patients Award Program which provides grants for innovative research focused on breast cancer.
Dr. Gomez brings CGH years of experience establishing, sustaining, and coordinating partnerships with for profit and non-profit organizations; contacts with an extensive network of investigators in various Latin American countries; and his skills as one of the few Spanish-speaking officials who has represented NCI, the U.S. Department of Health and Human Services, and the federal government in general. Under his leadership, NCI's cancer research activities in Latin America will continue to advance cancer care for Hispanic populations living both in the United States and in Latin America.